OKLAHOMA CITY, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian and microbial biologics, announces the appointment of Mr. Bin Zhang as Chief Executive Officer. Mr. Zhang served two months as Interim CEO before this formal appointment by the board to CE Read more...
Dublin, April 27, 2021 (GLOBE NEWSWIRE) -- The Read more...
